Stay updated on Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:23:21.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study record, indicating an access restriction to the content for that entry.
    Difference
    0.5%
    Check dated 2026-09-30T00:13:59.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page, replacing the previous detailed trial record. This change results in an accessible error screen instead of trial information.
    Difference
    21%
    Check dated 2026-09-23T01:09:24.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision label Revision: v3.7.0 appears on the page, replacing the previous Revision: v3.6.6.
    Difference
    0.0%
    Check dated 2026-09-15T23:58:58.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page shows a patch-level version update, updating from v3.6.5 to v3.6.6. This indicates a behind-the-scenes update to the system rather than a change to the displayed content.
    Difference
    0.0%
    Check dated 2026-09-01T20:42:36.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, replacing the previous v3.6.4 and indicating an update to the page's metadata.
    Difference
    0.0%
    Check dated 2026-08-11T16:25:48.000Z thumbnail image

Stay in the know with updates to Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.